• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮性卵巢癌患者最佳肿瘤可切除性的术前预测因素

Preoperative Predictors of Optimal Tumor Resectability in Patients With Epithelial Ovarian Cancer.

作者信息

Okunade Kehinde S, Soibi-Harry Adaiah P, Osunwusi Benedetto, Ohazurike Ephraim, John-Olabode Sarah O, Okunowo Adeyemi, Rimi Garba, Salako Omolola, Adenekan Muisi, Anorlu Rose

机构信息

Obstetrics and Gynaecology, Lagos University Teaching Hospital, Lagos, NGA.

Obstetrics and Gynaecology, College of Medicine, University of Lagos, Lagos, NGA.

出版信息

Cureus. 2022 Jan 19;14(1):e21409. doi: 10.7759/cureus.21409. eCollection 2022 Jan.

DOI:10.7759/cureus.21409
PMID:35198316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8855641/
Abstract

Background Several studies have shown that whether complete tumor resection can be achieved during debulking surgery depends on various patient-related factors. However, none of these studies was conducted among patients with epithelial ovarian cancer (EOC) in sub-Saharan Africa. In this study, we aimed to determine the preoperative predictors of optimal tumor resectability (OTR) during primary debulking surgery (PDS) in patients with EOC. Methodology In this study, we reviewed all patients with histologically diagnosed EOC who underwent PDS between January 2011 and December 2020. We included 83 patients with complete clinical records for subsequent data analysis. Descriptive statistics were computed for patients' data, and binary logistic regression analysis was used to assess the strength of associations between patients' preoperative characteristics and OTR. Results The overall rate of OTR was 53.0%, while the rate in advanced EOC patients was 36.1%. In the univariate analyses, pleural effusion, ascites, tumor bilaterality, size of the largest tumor, retroperitoneal lymph nodes, omental caking, peritoneal thickening, significant extrapelvic tumor, serum cancer antigen-125 (CA-125) levels, and hemoglobin levels were recorded as the predictors of OTR. However, after adjusting for covariates in the final multivariate models, we found that the absence of moderate-to-large pleural effusion (odds ratio (OR) = 5.60; 95% confidence interval (CI) = 1.32, 23.71) and having serum CA-125 levels of ≤370 U/mL (OR = 6.80; 95% CI = 1.19, 38.79) were the overall independent predictors of OTR while not having any preexisting comorbidity (OR = 18.21; 95% CI = 2.40, 38.10), and the absence of pleural effusions (OR = 13.75; 95% CI = 1.80, 24.85) or enlarged retroperitoneal lymph nodes (OR = 11.95; 95% CI = 1.35, 16.07) were predictors of OTR in advanced EOC patients. Conclusions We demonstrated that the radiological absence of pleural effusions and enlarged retroperitoneal lymph nodes and having no preexisting medical morbidity and serum CA-125 levels of ≤370 U/mL were the independent predictors of OTR during PDS. The preliminary data generated from this study can be used to develop variables for a prediction model in a future validation study.

摘要

背景

多项研究表明,肿瘤减瘤手术能否实现完全肿瘤切除取决于多种与患者相关的因素。然而,这些研究均未在撒哈拉以南非洲的上皮性卵巢癌(EOC)患者中进行。在本研究中,我们旨在确定EOC患者初次减瘤手术(PDS)期间最佳肿瘤可切除性(OTR)的术前预测因素。

方法

在本研究中,我们回顾了2011年1月至2020年12月期间接受PDS且经组织学诊断为EOC的所有患者。我们纳入了83例有完整临床记录的患者用于后续数据分析。对患者数据进行描述性统计,并使用二元逻辑回归分析评估患者术前特征与OTR之间关联的强度。

结果

OTR的总体发生率为53.0%,而晚期EOC患者的发生率为36.1%。在单因素分析中,胸腔积液、腹水、肿瘤双侧性、最大肿瘤大小、腹膜后淋巴结、网膜饼状增厚、腹膜增厚、显著的盆腔外肿瘤、血清癌抗原125(CA-125)水平和血红蛋白水平被记录为OTR的预测因素。然而,在最终的多变量模型中对协变量进行调整后,我们发现无中至大量胸腔积液(比值比(OR)=5.60;95%置信区间(CI)=1.32,23.71)以及血清CA-125水平≤370 U/mL(OR =6.80;95%CI =1.19,38.79)是OTR的总体独立预测因素,而无任何既往合并症(OR =18.21;95%CI =2.40,38.10)、无胸腔积液(OR =13.75;95%CI =1.80,24.85)或腹膜后淋巴结未肿大(OR =11.95;95%CI =1.35,16.07)是晚期EOC患者OTR的预测因素。

结论

我们证明,影像学上无胸腔积液和腹膜后淋巴结未肿大、无既往病史以及血清CA-125水平≤370 U/mL是PDS期间OTR的独立预测因素。本研究产生的初步数据可用于在未来的验证研究中开发预测模型的变量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b627/8855641/ef58689a8421/cureus-0014-00000021409-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b627/8855641/ef58689a8421/cureus-0014-00000021409-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b627/8855641/ef58689a8421/cureus-0014-00000021409-i01.jpg

相似文献

1
Preoperative Predictors of Optimal Tumor Resectability in Patients With Epithelial Ovarian Cancer.上皮性卵巢癌患者最佳肿瘤可切除性的术前预测因素
Cureus. 2022 Jan 19;14(1):e21409. doi: 10.7759/cureus.21409. eCollection 2022 Jan.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
5
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
6
Blood biomarkers for the non-invasive diagnosis of endometriosis.用于子宫内膜异位症无创诊断的血液生物标志物。
Cochrane Database Syst Rev. 2016 May 1;2016(5):CD012179. doi: 10.1002/14651858.CD012179.
7
Optimal primary surgical treatment for advanced epithelial ovarian cancer.晚期上皮性卵巢癌的最佳初次手术治疗
Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD007565. doi: 10.1002/14651858.CD007565.pub2.
8
Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.用于治疗复发性上皮性卵巢癌的促黄体生成素释放激素(LHRH)激动剂。
Cochrane Database Syst Rev. 2016 Jun 29;2016(6):CD011322. doi: 10.1002/14651858.CD011322.pub2.
9
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.超根治性(广泛)手术与标准手术治疗晚期上皮性卵巢癌的初步细胞减灭术。
Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD007697. doi: 10.1002/14651858.CD007697.pub3.
10
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.聚(ADP-核糖)聚合酶(PARP)抑制剂治疗卵巢癌。
Cochrane Database Syst Rev. 2022 Feb 16;2(2):CD007929. doi: 10.1002/14651858.CD007929.pub4.

引用本文的文献

1
Significance of Pretreatment Hemoglobin-Albumin-Lymphocyte-Platelet Index for the Prediction of Suboptimal Surgery in Epithelial Ovarian Cancer.术前血红蛋白-白蛋白-淋巴细胞-血小板指数对预测上皮性卵巢癌手术效果欠佳的意义
World J Oncol. 2024 Apr;15(2):268-278. doi: 10.14740/wjon1778. Epub 2024 Mar 21.
2
Survival outcomes following interval versus primary debulking surgery in advanced epithelial ovarian cancer: A retrospective cohort study in Lagos, Southwest Nigeria.晚期上皮性卵巢癌行间隔减瘤手术与初次减瘤手术的生存结局:尼日利亚西南部拉各斯的一项回顾性队列研究
Res Sq. 2024 Jan 5:rs.3.rs-3834135. doi: 10.21203/rs.3.rs-3834135/v1.

本文引用的文献

1
Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria.尼日利亚拉各斯上皮性卵巢癌初次治疗后的生存结局预测因素。
JCO Glob Oncol. 2021 Jan;7:89-98. doi: 10.1200/GO.20.00450.
2
Risk predictors of early recurrence in women with epithelial ovarian cancer in Lagos, Nigeria.尼日利亚拉各斯上皮性卵巢癌患者早期复发的风险预测因素。
Pan Afr Med J. 2020 Aug 12;36:272. doi: 10.11604/pamj.2020.36.272.17827. eCollection 2020.
3
Model for Prediction of Optimal Debulking of Epithelial Ovarian Cancer.上皮性卵巢癌最佳肿瘤细胞减灭术预测模型
Asian Pac J Cancer Prev. 2018 May 26;19(5):1319-1324. doi: 10.22034/APJCP.2018.19.5.1319.
4
A novel index for preoperative, non-invasive prediction of macro-radical primary surgery in patients with stage IIIC-IV ovarian cancer-a part of the Danish prospective pelvic mass study.一种用于术前非侵入性预测IIIC-IV期卵巢癌患者进行宏观根治性初次手术的新型指标——丹麦盆腔肿块前瞻性研究的一部分
Tumour Biol. 2016 Sep;37(9):12619-12626. doi: 10.1007/s13277-016-5166-z. Epub 2016 Jul 20.
5
Prediction of incomplete primary debulking surgery in patients with advanced ovarian cancer: An external validation study of three models using computed tomography.预测晚期卵巢癌患者不完全肿瘤细胞减灭术:基于 CT 的三个模型的外部验证研究。
Gynecol Oncol. 2016 Jan;140(1):22-8. doi: 10.1016/j.ygyno.2015.11.022. Epub 2015 Nov 24.
6
Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer.新诊断晚期卵巢癌残留病灶预测模型的开发
Gynecol Oncol. 2015 Jul;138(1):70-7. doi: 10.1016/j.ygyno.2015.04.013. Epub 2015 Apr 22.
7
Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care.新诊断晚期上皮性卵巢癌患者最佳肿瘤细胞减灭术的预测因素:是时候将腹腔镜评估纳入护理标准了。
Gynecol Oncol. 2015 Jun;137(3):553-8. doi: 10.1016/j.ygyno.2015.03.049. Epub 2015 Mar 28.
8
Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182.积极的手术能否改善预后?术前疾病负担与晚期卵巢癌复杂手术的相互作用:GOG 182 分析。
J Clin Oncol. 2015 Mar 10;33(8):937-43. doi: 10.1200/JCO.2014.56.3106. Epub 2015 Feb 9.
9
Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings.使用计算机断层扫描和术中发现预测晚期卵巢癌患者的手术结果
Taiwan J Obstet Gynecol. 2014 Sep;53(3):343-7. doi: 10.1016/j.tjog.2013.10.041.
10
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.一项多中心前瞻性研究,评估术前 CT 扫描和血清 CA-125 预测晚期卵巢癌、输卵管癌和腹膜癌初次肿瘤细胞减灭术时非理想减瘤的能力。
Gynecol Oncol. 2014 Sep;134(3):455-61. doi: 10.1016/j.ygyno.2014.07.002. Epub 2014 Jul 11.